<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=192888919167017&amp;ev=PageView&amp;noscript=1">
Wednesday,  November 27 , 2024

Linkedin Pinterest
Businessright chevron arrow icon

Columnists

Berko: Time may relieve folly of buying Flexion shares

September 3, 2017, 6:00am Business

Dear Mr. Berko: I have bad osteoarthritis in my knee and read about a new drug called Zilretta (not out yet), which is supposed to bring lasting relief. It’s made by a small biotech firm, called Flexion Therapeutics. Last March, my stockbroker told me that Flexion was going to be… Read story

Berko: Don’t get sucked into ‘art investment’

September 2, 2017, 6:01am Business

Dear Mr. Berko: I’ve been given the opportunity to invest in Treasure Investments Corp. by CEO Mark Russo. The investment consists of buying stock at 20 cents a share with a minimum investment of $25,000. The goal is to raise $10 million. The strategic plan is taking the company public… Read story

Singletary: Don’t be fooled by flood scams

September 1, 2017, 6:01am Business

With every natural disaster come the scams. Read story

Singletary: Effort helps put dent in student debt

August 30, 2017, 6:05am Business

There are two words that can rock people with regret. Read story

Brunell: U.S. must be cautious on taxing robots

August 29, 2017, 6:01am Business

Last February, the European Parliament rejected a tax on robots, but took the first steps to regulate their development and deployment. The legislation also aims to establish liability for the actions of robots including self-driving vehicles. Read story

Harney: What’s it take to be in equity elite?

August 28, 2017, 6:00am Business

Americans readily gossip about home values — “Did you hear the crazy high price the house down the street sold for?” “Did you hear how little our neighbors were forced to take on their sale?” Read story

Berko: Honesty requires full disclosure from stockbroker

August 27, 2017, 6:00am Business

Dear Mr. Berko: In March 2013, I bought 500 shares of Nektar Therapeutics at $12. In March of this year, it traded at $24, but now it trades around $19. Should I sell this stock or continue to hold and see whether it will go higher? In June 2013, I… Read story

Berko: Pass on PPL; there are better utilities

August 26, 2017, 6:00am Business

Dear Mr. Berko: At 63, I need income and growth. I recently retired after 34 years with the same company. I moved my $388,000 401(k), which owned a group of lousy mutual funds, into an individual retirement account and control my own investing. My new stockbroker had me buy Pfizer,… Read story

Singletary: Financial freedom for children can pay off

August 25, 2017, 6:01am Business

I’ve always struggled with how much financial freedom to give my children. Read story

Singletary: Do you have get-out-of-debt disorder?

August 23, 2017, 6:00am Business

There’s a group of people who suffer from what I’d call “serial get-out-of-debt disorder.” Read story